For press inquiries click here to contact us.
Bloomberg
Aimmune’s Peanut Allergy Drug Desensitizes Patients In Trial
FierceBiotech
Gene Therapy Pioneer ReGenX Raises $70.5M To Go It Alone
CNBC
The Holy Grail Of Treating Disease: Intarcia
MarketWatch
Next Generation Sequencing (NGS) Markets 2015
Fortune
Term Sheet – Tuesday, April 28: Intarcia Royal Pump
The Wall Street Journal
Startup Intarcia Raises $225 Million
MarketWatch
Novartis Accelerates Cancer Immunotherapy Efforts With Aduro Biotech Alliance And Launch Of New Immuno-Oncology Research Group
Healthcare Finance News
Aimmune Therapeutics Scores $80 Million In Financing To Back Peanut Allergy Treatment
Xconomy
Aimmune Therapeutics Takes $80M Series B For Phase 3 Peanut Allergy Trial
Please see important disclaimers in the Terms section.
